Blood cholesterol levels of 32-year-old alcohol consumers are better than of nonconsumers

Pharmacology Biochemistry and Behavior

Volumn 66, Issue 1, 2000, Pages 163-167

  Koppes, Lando L J ^a   Twisk, Jos W R ^a   Snel, Jan ^a   Van Mechelen, Willem ^a,b   Kemper, Han C G ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Alcohol; Beer; Blood cholesterol; Ethanol; HDL; Smoking; Spirits; Wine

Indexed keywords

ALCOHOL; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BEER; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CORONARY ARTERY DISEASE; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; WINE;

ADULT; ALCOHOL DRINKING; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; MALE; REGRESSION ANALYSIS;

EID: 0034109743     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(00)00195-7     Document Type: Article

References (47)

1. Abell L.L., Levy B.B., Brody B.B., Kendall F.E. Simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. J. Biol. Chem. 195:1957;357-366.
2. Blokstra A., Seidell J.C., Smit H.A., Bueno de Mesquita H.B., Verschuren W.M.M. The monitoring project on risk factors for chronic diseases (MORGEN-project), report 263200007. 1998;National Institute of Public Health and the Environment (RIVM), Bilthoven.
3. Burstein M., Samaille J. Sur un dosage rapide du cholesterol lié aux alpha- et aux bètalipoproteinen du serum. Clin. Chim. Acta. 5:1960;609-611.
4. Camargo C.A., Williams P.T., Vranizan K.M., Albers J.J., Wood P.D. The effect of moderate alcohol intake on serum apolipoproteins A-I and A-II. A controlled study JAMA. 253:1985;2854-2857.
5. Criqui M.H., Cowan L.D., Tyroler H.A., Bangdiwala S., Heiss G., Wallace R.B., Cohn R. Lipoproteins as mediators for the effects of alcohol consumption and cigarette smoking on cardiovascular mortality. Results from the lipid research clinics follow-up study Am. J. Epidemiol. 126:1987;629-637.
6. Frankel E.N., Kanner J., German J.B., Parks E., Kinsella J.E. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet. 341:1993;454-457.
7. Fuchs C.S., Stampfer M.J., Colditz G.A., Giovannucci E.L., Manson J.E., Kawachi I., Hunter D.J., Hankinson S.E., Hennekens C.H., Rosner B., Speizer F.E., Willett W.C. Alcohol consumption and mortality among women. N. Engl. J. Med. 332:1995;1245-1250.
8. Grønbæk M., Deis A., Sørensen T.I.A., Becker U., Schnohr P., Jensen G. Mortality associated with moderate intakes of wine, beer, or spirits. Br. Med. J. 310:1995;1165-1169.
9. Grønbæk M., Sørensen T.I.A. Alcohol consumption and risk of coronary heart disease. Br. Med. J. 313:1996;365.
10. Hein H.O., Suadicani P., Gyntelberg F. Alcohol consumption, serum low density lipoprotein cholesterol concentration, and risk of ischaemic heart disease. Six year follow up in the Copenhagen male study Br. Med. J. 312:1996;736-741.
11. Hendriks H.F.J., Veenstra J., Velthuis-te Wierik E.J.M., Schaafsma G., Kluft C. Effect of moderate dose of alcohol with evening meal on fibrinolytic factors. Br. Med. J. 308:1994;1003-1006.
12. Hertog M.G.L., Feskens E.J.M., Hollman P.C.H., Katan M.B., Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease. The Zutphen elderly study Lancet. 342:1993;1007-1011.
13. Holman C.D.J., English D.R., Milne E., Winter M.G. Meta-analysis of alcohol and all-cause mortality. A validation of NHMRC recommendations Med. J. Aust. 164:1996;141-145.
14. Huang T.C., Chen C.P., Wefler V., Raftery A. A stable reagent for the Lieberman-Buchard reaction. Anal. Chem. 33:1961;1405-1407.
15. Iso H., Koike K.A., Folsom A.R., Shimamoto T., Sato S., Lida M., Komachi Y. Lipoprotein(a) and its correlates in Japanese and U.S. population samples. Ann. Epidemiol. 6:1996;324-330.
16. Kemper H.C.G. Growth, health and fitness of teenagers. Longitudinal research in international perspective. Medicine and sport science, vol. 20:1985;Karger, Basel.
17. Kemper H.C.G. The Amsterdam growth and health study. A longitudinal analysis of health, fitness and lifestyle. HK sport science monograph series, vol. 6:1995;Human Kinetics, Champaign, IL.
18. Kiechl S., Willeit J., Rungger G., Egger G., Oberhollenzer F., Bonora E. Alcohol consumption and atherosclerosis. What is the relation? Prospective results from the Bruneck study Stroke. 29:1998;900-907.
19. Klatsky A.L., Armstrong M.A., Friedman G.D. Relations of alcoholic beverage use to subsequent coronary artery disease hospitalization. Am. J. Cardiol. 58:1986;710-714.
20. Klatsky A.L., Armstrong M.A., Friedman G.D. Risk of cardiovascular mortality in alcohol drinkers, ex-drinkers and nondrinkers. Am. J. Cardiol. 66:1990;1237-1242.
21. Klatsky A.L., Armstrong M.A., Friedman G.D. Alcohol and mortality. Ann. Intern. Med. 117:1992;646-654.
22. Klatsky A.L., Armstrong M.A. Alcoholic beverage choice and risk of coronary artery disease mortality. Do red wine drinkers fare best? Am. J. Cardiol. 71:1993;467-469.
23. Klatsky A.L., Armstrong M.A., Friedman G.D. Red wine, white wine, liquor, beer, and risk for coronary artery disease hospitalization. Am. J. Cardiol. 80:1997;416-420.
24. Langer R.D., Criqui M.H., Reed D.M. Lipoproteins and blood pressure as biological pathways for effect of moderate alcohol consumption on coronary heart disease. Circulation. 85:1992;910-915.
25. Maclure M. Demonstration of deductive meta-analysis. Ethanol intake and risk of myocardial infarction Epidemiol. Rev. 15:1993;328-351.
26. Margaglione M., Cappucci G., Donatella C., Pirro L., Vecchione G., Grandone E., Di Minno G. Fibrinogen plasma levels in an apparently healthy general population - Relation to environmental and genetic determinants. Thromb. Haemost. 80:1998;805-810.
27. Marmot M., Brunner E. Alcohol and cardiovascular disease. The status of the U shaped curve Br. Med. J. 303:1991;565-568.
28. Montoye H.J., Kemper H.C.G., Saris W.H.M., Washburn R.A. Measuring physical activity and energy expenditure. 1996;Human Kinetics, Champaign, IL. 123-183.
29. Alcoholgebruik in beeld; Standaardmeetlat. 1998;NEI, Rotterdam.
30. Paassilta M., Kervinen K., Rantala A.O., Savolainen M.J., Lija M., Reunanen A., Resäniemi Y.A. Social alcohol consumption and low Lp(a) lipoprotein concentrations in middle aged Finnish men. Population based study Br. Med. J. 316:1998;594-595.
31. Pearson T.A., Kuller L.H. Pathogenesis of atherosclerosis; Effects of alcohol on lipoprotein metabolism; Epidemiologic data. In. Steinberg, D., ed. Alcohol and atherosclerosis Ann. Intern. Med. 114:1991;967-996.
32. Poikolainen K. Alcohol and mortality. A review J. Clin. Epidemiol. 48:1995;455-465.
33. Post G.B. Nutrition in adolescence. A longitudinal study in dietary patterns from teenager to adult:1989;De Vrieseborch, Haarlem.
34. Renaud S., Criqui M.H., Farchi G., Veenstra J. Alcohol drinking and coronary heart disease. Verschuren P.M. Health issues related to alcohol consumption. 1993;81-123 ILSI Press, Washington, DC.
35. Rhoads G.G., Dahlen G., Berg K., Morton M.E., Dannenberg A.L. Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA. 256:1986;2540-2544.
36. Ridker P.M., Vaughan D.E., Stampfer M.J., Glynn R.J., Hennekens C.H. Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator. JAMA. 272:1994;929-933.
37. Rimm E.B., Giovannucci E.L., Willett W.C., Colditz G.A., Ascherio A., Rosner B., Stampfer M.J. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet. 338:1991;464-468.
38. Rimm E.B., Klatsky A., Grobbee D., Stampfer M.J. Review of moderate alcohol consumption and reduced risk of coronary heart disease. is the effect due to beer, wine, or spirits? Br. Med. J. 312:1996;731-736.
39. Scarabin P.-Y., Aillaud M.-F., Amouyes P., Evans A., Luc G., Ferrières J., Arveiler D., Juhan-Vague I. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction. Thromb. Haemost. 80:1998;749-856.
40. Shaten B.J., Kuller L.H., Neaton J.D. Association between baseline risk factors, cigarette smoking and CHD mortality after 10.5 years. Prev. Med. 20:1991;655-669.
41. Stampfer M.J., Conditz G.A., Willett W.C., Speizer F.E., Hennekens C.H. A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N. Engl. J. Med. 319:1988;267-273.
42. Suh I., Shaten B.J., Cutler J.A., Kuller L.H. Alcohol use and mortality form coronary heart disease. The role of high-density lipoprotein cholesterol Ann. Intern. Med. 116:1992;881-887.
43. Swinkels H. Use of alcoholic beverages in The Netherlands - A comparison of some survey methods. Monthly Bull. Health Stat. (CBS). 10:1991;5-12.
44. Tjønneland Z., Grønbæk M., Stripp C., Overvad K. Wine intake and diet in a random sample of 48763 Danish men and women. Am. J. Clin. Nutr. 69:1999;49-54.
45. Truelsen T., Grønbæk M., Schnohr P., Boysen G. Intake of beer, wine, and spirits and risk of stroke. The Copenhagen city heart study Stroke. 29:1998;2467-2472.
46. Valmadrid C.T., Klein R., Moss S.E., Klein B.E.K., Cruickshanks K.J. Alcohol intake and the risk of coronary heart disease mortality in persons with older-onset diabetes mellitus. JAMA. 282:1999;239-246.
47. Wannamethee S.G., Shaper A.G. Type of alcoholic drink and risk of major coronary heart disease and all-cause mortality. Am. J. Public Health. 89:1999;685-690.